UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Discover how to utilize your skills to generate extra cash. Unlock new income opportunities today.
20,528 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Quantum dreams meet market drama as Rigetti and peers grab headlines. This guide breaks down why rigetti computing st...
A small cadre of high-priced stocks stubbornly resist stock splits even as peers embrace them. Here are four names le...
Celebrity comebacks aren’t just headlines—they reshape money decisions. This piece breaks down how david beckham’s co...
Billionaire investor Bill Ackman warns that today's mega-cap trio—Microsoft, Meta, and Amazon—could echo Buffett's Be...
Imagine a world where SpaceX launches an IPO in July. This article breaks down how a price target could form, the big...
Alphabet stock already fuels your tech exposure. If SpaceX goes public, should spacex after already owning Alphabet b...
Sandisk stock just jumped, and investors want to know why. This article breaks down the key catalysts behind the move...
When a high-profile artist hits legal trouble, the financial ripple effects can be wide. This article looks at how ba...
A major insider purchase by BORR's Executive Director has investors buzzing. This article breaks down what the move c...
Beijing injects 300 billion yuan into short-term funding through an overnight reverse repo, a move traders are watchi...
Long-term wealth isn’t built overnight. These dividend ETF picks could deliver steady income, steady growth, and the ...